School wins gold medals for innovation at global event
Compiled by TAN SIN CHOW AND R. ARAVINTHAN
PUPILS from SJK(T) Taman Permata in Dengkil, Selangor, won six gold medals at an international innovation competition, Malaysia Nanban reported.
Six teams from the school – comprising pupils from Year Two to Year Six – won medals at the 3rd International Invention and Innovation Competition 2025.
The event, organised by the Malaysia Innovation, Invention and Creativity Association (Miica), was held at Akademi Seni Budaya and Warisan Kebangsaan in Kuala Lumpur.
The school's headmaster Ravi Subramaniam congratulated the pupils and thanked science teacher Saraswathy Munian for training the winning teams.
Their success was made sweeter by Saraswathy also winning an award at the event.
She was one of the 20 teachers worldwide who received the best teacher award in various categories from 381 teachers who were nominated.
Miica president Ganesan Jayabalan handed out the prizes to the winning pupils.
(The above articles are compiled from the vernacular newspapers (Bahasa Malaysia, Chinese and Tamil dailies). As such, stories are grouped according to the respective language/medium. Where a paragraph begins with a >, it denotes a separate news item.)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sinar Daily
an hour ago
- Sinar Daily
New T-Rex ancestor discovered in drawers of Mongolian institute
The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus. 21 Jun 2025 06:00pm This handout artist's illustration made available by University of Calgary on June 6, 2025, shows the newly discovered dinosaur species Khankhuuluu mongoliensis, an ancestor of Tyrannosaurus Rex. Misidentified bones that languished in the drawers of a Mongolian institute for 50 years belong to a new species of tyrannosaur that rewrites the family history of the mighty T-Rex, scientists said on June 11, 2025. (Photo by Julius CSOTONYI / University of Calgary / AFP) PARIS - Misidentified bones that languished in the drawers of a Mongolian institute for 50 years belong to a new species of tyrannosaur that rewrites the family history of the mighty T-Rex, scientists said Wednesday. This slender ancestor of the massive Tyrannosaurus Rex was around four metres (13 feet) long and weighed three quarters of a tonne, according to a new study in the journal Nature. "It would have been the size of a very large horse," study co-author Darla Zelenitsky of Canada's University of Calgary told AFP. The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus. For half a century, the fossils sat in the drawers at the Institute of Paleontology of the Mongolian Academy of Sciences in the capital Ulaanbaatar. Then PhD student Jared Voris, who was on a trip to Mongolia, started looking through the drawers and noticed something was wrong, Zelenitsky said. It turned out the fossils were well-preserved, partial skeletons of two different individuals of a completely new species. "It is quite possible that discoveries like this are sitting in other museums that just have not been recognised," Zelenitsky added. 'Messy' family history They named the new species Khankhuuluu mongoliensis, which roughly means the dragon prince of Mongolia because it is smaller than the "king" T-Rex. Zelenitsky said the discovery "helped us clarify a lot about the family history of the tyrannosaur group because it was really messy previously". The T-Rex represented the end of the family line. It was the apex predator in North America until 66 million years ago, when an asteroid bigger than Mount Everest slammed into the Gulf of Mexico. Three quarters of life on Earth was wiped out, including all the dinosaurs that did not evolve into birds. Around 20 million years earlier, Khankhuuluu -- or another closely related family member -- is now believed to have migrated from Asia to North America using the land bridge that once connected Siberia and Alaska. This led to tyrannosaurs evolving across North America. Then one of these species is thought to have crossed back over to Asia, where two tyrannosaur subgroups emerged. One was much smaller, weighing under a tonne, and was nicknamed Pinocchio rex for its long snout. The other subgroup was huge and included behemoths like the Tarbosaurus, which was only a little smaller than the T-rex. One of the gigantic dinosaurs then left Asia again for North America, eventually giving rise to the T-Rex, which dominated for just two million years -- until the asteroid struck. - AFP
The Star
15 hours ago
- The Star
Chinese team's edible fruit coating can more than double shelf life: paper
Chinese scientists have developed an edible, washable protein-based coating that can extend the shelf life of fruit by 2½ times, by reducing moisture loss and microbial growth. The low-cost coating was tested across 17 varieties of whole and cut fruits, including strawberry, tomato, kiwi and mango. It was shown to effectively delay rot by almost a week or more, at a cost of just 9 US cents per kilogram of fruit, according to a paper in the peer-reviewed journal Nature Communications. The new strategy is as effective as existing preservation methods but reduces carbon dioxide emissions and the potential for toxicity, offering a promising solution to a major factor in global food waste. 'Addressing critical challenges in perishable fruit preservation ... we present an eco-friendly amyloid-like protein coating strategy developed through computer-aided molecular simulation,' the team led by researchers at Shaanxi Normal University said in their paper published on May 31. 'With edible properties, easy washability, and low cost, the coating demonstrates universal applicability for post-harvest and fresh-cut fruits.' Around a third of all food produced globally is wasted, most of it perishable items like fruit and vegetables. While all fruit have a natural protective barrier on their surface, harvesting renders them easily perishable due to dehydration, microbial growth, oxidation and ageing, thus limiting shelf life. Strategies explored to extend the shelf life of fruit include genetic modification, wax coating, cold storage, and using 'harmful' chemical preservatives such as formaldehyde. While the waxing of fruit is widely adopted, there are concerns over the health implications of long-term consumption, due to the potential of wax to restrict oxygen and carbon dioxide exchange, according to the research team. Meanwhile, cold storage may be more biosafe than some of the other methods, but it is expensive and energy-intensive, which adds to global carbon emissions. Functional coating technologies using natural substances are a promising alternative, but developing a combination of materials that can evenly spread and adhere over the water-repellent fruit cuticle poses a challenge. The researchers chose to use a phase-transitioned, amyloid-like protein, a type of material that is used to make underwater adhesives and stain-resistant fabric coatings. Amyloid-like proteins are soluble and can be sprayed onto the surface of fruit. The researchers combined this with molecules of antimicrobial materials to make their coating. 'The superior performance of the amyloid-like protein coating stems from its enhanced spreadability, film formation, adhesion robustness and uniformity on fruit surfaces, which result in improved coating stability and prolonged preservation,' the team said in the paper. 'Our coating reduces carbon emissions by 90 per cent compared to standard refrigeration practices while extending shelf life by 2.5 times.' The coating can delay fruit rot while achieving 60 to 98 per cent nutrient retention, which is more efficient than chemical preservation without the risk of toxicity, according to the paper. While bare strawberries showed noticeable signs of decay after four days and severe fungal growth by day 10, the coated strawberries showed no apparent decay over this period. The coating was able to extend the shelf life of cherry tomatoes from six to 16 days, kumquats from 15 to 30 days, and from two to eight days for both bananas and mangoes. The material was also able to function under high temperatures, extending the shelf life of strawberries by three days under 42 degrees Celsius (107.6 degrees Fahrenheit). While freshly cut uncoated apples showed bacterial presence on day two, the coated ones did not show such signs until day eight, indicating that the coating could delay browning and decay even on cut and peeled fruit. 'These findings underscore the universal fresh-keeping capability of the [coating] for fruit, doubling or even quintupling the typical shelf life of highly perishable fruits,' the team said. Researchers from Tianjin University, Xinjiang Normal University, Changan University and the Second Affiliated Hospital of Xian Jiaotong University also took part in the study. The biosafety of the coating was tested by feeding rats with spray-coated rat food. The animals exhibited no 'distinct pathological alterations' and their blood, kidney and liver function tests were normal. 'The biocompatible, edible, and easily washable nature of the [amyloid-like protein] coating provides a practical and safer alternative for food preservation,' the team asserted. -- SOUTH CHINA MORNING POST
New Straits Times
4 days ago
- New Straits Times
China pharma projects disrupted by Sino-US tensions
SHANGHAI: Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling supplies and discussing testing locally, said sources with knowledge of the matter, as they seek to mitigate the impact of US-China trade tensions. China's sprawling pharmaceutical research and manufacturing sector serves global drug giants such as Pfizer and AstraZeneca with a low-cost development model that often uses imported clinical samples, equipment, chemicals and other materials to conduct work. Fears of delay in access to US supply chains and raised import tariffs are spurring biotech and pharmaceutical companies to avoid, pause or consider delaying the start of projects, according to three sources. They are also discussing testing US clinical samples in the US, instead of sending them to China for further research, a move that could increase costs, and requesting additional supplies for backup, three other sources said. The six sources who spoke to Reuters are director or executive-level employees involved in various aspects of the industry in China including research and development, manufacturing and supply chains. All but two agreed to speak only on condition of anonymity because of concerns about effects on fundraising plans or they were not authorised to speak to media. The developments have not been reported previously. US and Chinese officials said last week they had agreed on a framework to put a May trade truce back on track and remove China's export restrictions on rare earths, but offered little sign of a durable resolution to longstanding trade differences that have affected products ranging from semiconductors and jet engines to medical equipment and pharmaceuticals. "What kind of long-term policy it could be, you know, what kind of tariff would it be in half a year, in one year... nobody knows. And that's the problem. That's what makes everybody worry and nervous," said Chen Gong, co-founder of NeuExcell Therapeutics, a biotech with its main operations in Suzhou. He said the US-China trade tensions had made him more cautious about investing in a clinical trial and the company would delay its start if it did not have sufficient funding. Reliance on US imports has come into particular focus as trade tensions escalate. In 2024, the US exported diagnostic and laboratory reagents to China valued at about US$1.4 billion and prepared culture media for the development or maintenance of microorganisms worth about US$125 million, U.N. Comtrade data showed. In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare industry, some US-made goods including diagnostic reagents from Germany's Siemens Healthineers were exempted from raised Chinese tariffs, that company said in May. China raised its tariffs on US imports to as much as 125 per cent though it has since reduced that to 10 per cent while it works out a more permanent trade deal. HIGHER COSTS, DELAYS WuXi AppTec and a Chinese biotechnology firm that was its research client agreed in May to switch US-made reagents they had been using for a Hepatitis B virus pre-clinical research project into non-U.S. versions due partly to concerns about higher costs from tariffs, a source at the client company said. The project had been temporarily paused during the discussions, which began prior to May, the source said. WuXi AppTec said it makes "every effort to avoid disruptions or delays in the delivery of services to customers." Since April, at least 17 Chinese biotech and pharmaceutical clients have contacted Chinese cell culture media manufacturer JS Biosciences asking it to keep locally-made backup raw materials for production because they were concerned about cost increases or the inability to access foreign supplies, the firm's CEO Luo Shun said. "If they have a product made by us, and we rely on the foreign raw material supply and that raw material will increase in price or is never going to come, obviously it will impact their manufacturing of those life-saving drugs. So obviously, that's their primary concern," Luo said. Another Chinese drug research and development firm decided not to provide a quotation to a foreign pharmaceutical company interested in hiring it for protein drug manufacturing, due to delays in obtaining necessary US-made culture medium from a US subsidiary of Japan's Fujifilm, a source at the Chinese firm said. The potential client would likely not have accepted waiting on imports of new supplies into China, which would typically take two to four months, the source said. A Fujifilm Holdings America Corporation spokesperson said Fujifilm Biosciences, one of its life science business units, has made significant investments to build a robust global manufacturing network so that it could navigate any challenges or disruptions, without elaborating on its supply issue involving China. STOCKPILING, US TESTING After China announced a large rise in tariffs for US imports in April, WuXi Biologics placed a bigger-than-normal order for reagents made in the US with a supplier because it was not sure how long that policy action would continue, said a source at the supplier. WuXi Biologics did not respond to requests for comment. Concerns about the potential for US export restrictions led China's Innovent Biologics and multinational BeOne Medicines to discuss with Massachusetts-headquartered Thermo Fisher Scientific the prospect of not sending US clinical samples to China, said a source at the US company. Testing US samples in-country instead of in China would be more expensive, the source said.
